TREATMENT WITH MDL 72527 AMELIORATED CLINICAL SYMPTOMS, RETINAL GANGLION CELL LOSS, OPTIC NERVE INFLAMMATION, AND IMPROVED VISUAL ACUITY IN AN EXPERIMENTAL MODEL OF MULTIPLE SCLEROSIS

Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis

Multiple Sclerosis (MS) is a highly disabling neurological disease characterized by inflammation, neuronal damage, and demyelination.Vision impairment is one of the major clinical features of MS.Previous studies from our lab have shown that MDL 72527, a pharmacological inhibitor of spermine oxidase (SMOX), is protective against neurodegeneration an

read more


Appreciating the image of God in all humanity: Towards a pastoral response to skin lightening as image enhancement to exit dark skin

The practice of skin Patio lightening is prevalent amongst dark-skinned people globally.Various current studies that map this practice and that seek motivations behind the practice are examined.It is observed that through shrewd marketing, dark-skinned people are offered a promise of a better quality of life, obtained by a lighter skin, through the

read more